Showing results 2 to 2 of 2
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
A randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2013 | 2013 | 98 |